JOURNAL ARTICLE

Antigenic and Immunogenic Properties of Baculovirus-Expressed Infectious Bursal Disease Viral Proteins

Jody K. DybingDaral J. Jackwood

Year: 1998 Journal:   Avian Diseases Vol: 42 (1)Pages: 80-80   Publisher: American Association of Avian Pathologists

Abstract

Genomic segment A of the variant Md infectious bursal disease virus (IBDV) was amplified by reverse transcriptase/polymerase chain reaction, cloned, and expressed in the baculovirus expression system. Three different baculovirus recombinants expressing the genes encoding VP2, VP2/VP4, and the complete polyprotein (VP2/VP4/VP3) were prepared. The three antigens were used in separate enzyme-linked immunosorbent assays, and each detected antibodies against the variant IBDV strains Md, Del-A, Del-E, and GLS and the classic IBDV strain D78 throughout a 14-wk period following vaccination. Eight-week-old specific-pathogen-free (SPF) chickens were inoculated subcutaneously using the VP2/VP4 or VP2/VP4/VP3 baculovirus recombinant or wild-type baculovirus-infected insect cell lysates. Virus-neutralizing antibodies were detected in the VP2/VP4 and VP2/VP4/VP3 baculovirus-inoculated birds at 13 days postinoculation (PI) and at 43 days PI when titrated against Md IBDV. No virus-neutralizing antibody titer was observed in the negative controls or wild-type baculovirus-inoculated birds. One-week-old SPF chickens were inoculated with the VP2, VP2/VP4/VP3 baculovirus recombinants or wild-type baculovirus-infected insect cell lysates. The birds were boosted 2 wk later and challenged at 4 wk of age with 0.5 ml/bird classic STC IBDV (10(2) median embryo infective dose [EID50]/ml) or variant Md IBDV (10(5) EID50/ml) via the oral/nasal route. The VP2 and VP2/VP4/VP3 baculovirus-inoculated birds were partially protected against challenge with the classic STC IBDV. The birds were protected against clinical disease and death but not bursal damage, whereas the wild-type baculovirus-inoculated birds exhibited clinical signs of disease, 13% mortality, and bursal damage. When challenged with the variant Md IBDV, neither the VP2, VP2/VP4/VP3 baculovirus recombinants nor the wild-type baculovirus elicited protection against bursal damage and atrophy.

Keywords:
Infectious bursal disease Virology Biology Virus Antibody Neutralizing antibody Antigen Titer Inoculation Gene Virulence Immunology Genetics

Metrics

30
Cited By
0.75
FWCI (Field Weighted Citation Impact)
31
Refs
0.69
Citation Normalized Percentile
Is in top 1%
Is in top 10%

Citation History

Topics

Viral Infectious Diseases and Gene Expression in Insects
Life Sciences →  Biochemistry, Genetics and Molecular Biology →  Molecular Biology
Vector-Borne Animal Diseases
Life Sciences →  Agricultural and Biological Sciences →  Ecology, Evolution, Behavior and Systematics
Entomopathogenic Microorganisms in Pest Control
Life Sciences →  Agricultural and Biological Sciences →  Insect Science

Related Documents

JOURNAL ARTICLE

Expression of MD Infectious Bursal Disease Viral Proteins in Baculovirus

Jody K. DybingDaral J. Jackwood

Journal:   Avian Diseases Year: 1997 Vol: 41 (3)Pages: 617-617
JOURNAL ARTICLE

5605827 Infectious bursal disease virus VP2 fusion protein expressed by baculovirus

Journal:   Biotechnology Advances Year: 1997 Vol: 15 (3-4)Pages: 747-747
JOURNAL ARTICLE

Antigenic Diversity of Infectious Bursal Disease Viruses

D H JackwoodY. Μ. Saif

Journal:   Avian Diseases Year: 1987 Vol: 31 (4)Pages: 766-766
© 2026 ScienceGate Book Chapters — All rights reserved.